BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 23892040)

  • 21. Acteoside inhibits melanogenesis in B16F10 cells through ERK activation and tyrosinase down-regulation.
    Son YO; Lee SA; Kim SS; Jang YS; Chun JC; Lee JC
    J Pharm Pharmacol; 2011 Oct; 63(10):1309-19. PubMed ID: 21899547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A derivative of imidazobenzimidazole, ML106, inhibits melanin synthesis via p38 MAPK activation.
    Kim SY; Lee SH; Shin JS; Lee D; Lee T; Park KC; Min KH; Kim DS
    Pharmazie; 2014 May; 69(5):353-7. PubMed ID: 24855826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a novel tyrosinase inhibitor, (2RS,4R)-2-(2,4-dihydroxyphenyl)thiazolidine-4-carboxylic acid (MHY384).
    Han YK; Park YJ; Ha YM; Park D; Lee JY; Lee N; Yoon JH; Moon HR; Chung HY
    Biochim Biophys Acta; 2012 Apr; 1820(4):542-9. PubMed ID: 22251576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2, 3, 5, 4'-tetrahydroxystilbene-2-O-beta-D-glucoside (THSG) induces melanogenesis in B16 cells by MAP kinase activation and tyrosinase upregulation.
    Jiang Z; Xu J; Long M; Tu Z; Yang G; He G
    Life Sci; 2009 Aug; 85(9-10):345-50. PubMed ID: 19527735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitory effects of adlay extract on melanin production and cellular oxygen stress in B16F10 melanoma cells.
    Huang HC; Hsieh WY; Niu YL; Chang TM
    Int J Mol Sci; 2014 Sep; 15(9):16665-79. PubMed ID: 25244016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guggulsterone inhibits melanogenesis in B16 murine melanoma cells by downregulating tyrosinase expression.
    Koo JH; Rhee KS; Koh HW; Jang HY; Park BH; Park JW
    Int J Mol Med; 2012 Oct; 30(4):974-8. PubMed ID: 22797252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta-carboline alkaloids harmaline and harmalol induce melanogenesis through p38 mitogen-activated protein kinase in B16F10 mouse melanoma cells.
    Park SY; Kim YH; Kim YH; Park G; Lee SJ
    BMB Rep; 2010 Dec; 43(12):824-9. PubMed ID: 21189160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isoorientin derived from Gentiana veitchiorum Hemsl. flowers inhibits melanogenesis by down-regulating MITF-induced tyrosinase expression.
    Wu QY; Wong ZC; Wang C; Fung AH; Wong EO; Chan GK; Dong TT; Chen Y; Tsim KW
    Phytomedicine; 2019 Apr; 57():129-136. PubMed ID: 30668315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of melanogenesis by gallic acid: possible involvement of the PI3K/Akt, MEK/ERK and Wnt/β-catenin signaling pathways in B16F10 cells.
    Su TR; Lin JJ; Tsai CC; Huang TK; Yang ZY; Wu MO; Zheng YQ; Su CC; Wu YJ
    Int J Mol Sci; 2013 Oct; 14(10):20443-58. PubMed ID: 24129178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of melanogenesis by a newly synthesized compound, MHY966 via the nitric oxide/protein kinase G signaling pathway in murine skin.
    Choi YJ; Uehara Y; Park JY; Chung KW; Ha YM; Kim JM; Song YM; Chun P; Park JW; Moon HR; Chung HY
    J Dermatol Sci; 2012 Dec; 68(3):164-71. PubMed ID: 23088959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ROS-scavenging and Anti-tyrosinase Properties of Crocetin on B16F10 Murine Melanoma Cells.
    Hashemi-Shahri SH; Golshan A; Mohajeri SA; Baharara J; Amini E; Salek F; Sahebkar A; Tayarani-Najaran Z
    Anticancer Agents Med Chem; 2018; 18(7):1064-1069. PubMed ID: 29237384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hirseins inhibit melanogenesis by regulating the gene expressions of Mitf and melanogenesis enzymes.
    Villareal MO; Han J; Yamada P; Shigemori H; Isoda H
    Exp Dermatol; 2010 May; 19(5):450-7. PubMed ID: 19765058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acanthoic acid inhibits melanogenesis through tyrosinase downregulation and melanogenic gene expression in B16 melanoma cells.
    Yoon WJ; Ham YM; Yoon HS; Lee WJ; Lee NH; Hyun CG
    Nat Prod Commun; 2013 Oct; 8(10):1359-62. PubMed ID: 24354173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Scopoletin Stimulates Melanogenesis via cAMP/PKA Pathway and Partially p38 Activation.
    Kim DS; Cha SB; Park MC; Park SA; Kim HS; Woo WH; Mun YJ
    Biol Pharm Bull; 2017 Dec; 40(12):2068-2074. PubMed ID: 28943528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aglycone of Rh4 inhibits melanin synthesis in B16 melanoma cells: possible involvement of the protein kinase A pathway.
    Jeong YM; Oh WK; Tran TL; Kim WK; Sung SH; Bae K; Lee S; Sung JH
    Biosci Biotechnol Biochem; 2013; 77(1):119-25. PubMed ID: 23291754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pyruvic acid/ethyl pyruvate inhibits melanogenesis in B16F10 melanoma cells through PI3K/AKT, GSK3β, and ROS-ERK signaling pathways.
    Zhou S; Sakamoto K
    Genes Cells; 2019 Jan; 24(1):60-69. PubMed ID: 30417494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dual inhibition of γ-oryzanol on cellular melanogenesis: inhibition of tyrosinase activity and reduction of melanogenic gene expression by a protein kinase A-dependent mechanism.
    Jun HJ; Lee JH; Cho BR; Seo WD; Kang HW; Kim DW; Cho KJ; Lee SJ
    J Nat Prod; 2012 Oct; 75(10):1706-11. PubMed ID: 23031087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Young leaves of reed (Phragmites communis) suppress melanogenesis and oxidative stress in B16F10 melanoma cells.
    Sim MO; Ham JR; Lee MK
    Biomed Pharmacother; 2017 Sep; 93():165-171. PubMed ID: 28628832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diphlorethohydroxycarmalol inhibits melanogenesis via protein kinase A/cAMP response element-binding protein and extracellular signal-regulated kinase-mediated microphthalmia-associated transcription factor downregulation in α-melanocyte stimulating hormone-stimulated B16F10 melanoma cells and zebrafish.
    Ding Y; Jiang Y; Im ST; Myung S; Kim HS; Lee SH
    Cell Biochem Funct; 2021 Jun; 39(4):546-554. PubMed ID: 33474761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A derivative of 2-aminothiazole inhibits melanogenesis in B16 mouse melanoma cells via glycogen synthase kinase 3β phosphorylation.
    Kim SY; Hahn HG; Nam KD; Park KC; Yun HY; Baek KJ; Kwon NS; Kim DS
    J Pharm Pharmacol; 2011 Aug; 63(8):1031-6. PubMed ID: 21718286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.